ArticleJournal of family medicine and primary care2025
Impact of treatment modality on cognition in older adults with type 2 diabetes mellitus.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cognitive impairment impacts functionality and health outcomes in older adults with diabetes mellitus. Crucially, managing diabetes involves many self-management activities that require adequate cognitive abilities. Pharmacological therapy for diabetes mellitus in older persons should address both cognitive functions and glycaemic control. Objective: To examine the relationship between the treatment modality of diabetes and cognitive functions in the elderly. Methodology: A cross-sectional hospital-based study of older adults with type 2 diabetes mellitus over 1 year was conducted. Sociodemographic, relevant clinical details were obtained; Mini-Mental Status Examination (MMSE), Digit Symbol Substitution Test (DSST), Rey Auditory Verbal Learning Test (RAVLT), Trail-Making B test, F-A-S fluency, and categorical fluency test were assessed. Descriptive statistics, a generalized linear model, and a structural equation model with path analysis were performed to understand the relationship between treatment modality for diabetes and cognitive functions in the elderly. Results: A total of 134 diabetic patients with a mean age of 68.06 + 6.29 years were assessed. The oral hypoglycaemic agent (OHA) treatment group has significantly better glycaemic control than the insulin group ( Conclusion: Compared to insulin, OHA has a beneficial effect on cognition in older adults with type 2 diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.